Including suicidal or potentially suicidal individuals in clinical research is a critical way to gain important data that can advance suicide prevention efforts. Researchers and IRBs may tend to exclude suicidal individuals from research studies to avoid potential risks; however, in order for the research to be scientifically and clinically valuable, it is important that suicidal individuals are not excluded from research unnecessarily. Implementing proper safety measures in the protocol can help mitigate potential risks and encourage safe and ethical participation of suicidal and potentially suicidal individuals in research.
This webinar will summarize the recently released National Institute of Mental Health (NIMH) guidance for conducting research with subjects at elevated risk of suicide*, focusing on the areas most relevant for IRBs, including considerations for informed consent, study design, safety monitoring and reporting, end of study participation, and the use of novel technologies in research. The webinar will also discuss practical applications to address these considerations, including the role of clinical care in mitigating risk. Potential negative consequences of excluding suicidal individuals in research will also be considered. The webinar will conclude with interactive case studies. (Presented on October 17, 2017)
What will I learn?
After attending this webinar, you will be able to:
- Support clinical researchers in including potentially suicidal individuals in their studies by directing them to resources that provide guidance on safe and ethical practice
- Evaluate inclusion and exclusion criteria for suicidal individuals’ participation in research
- Evaluate the appropriateness of risk assessment and mitigation strategies proposed in a study protocol
Who should attend?
This webinar will be beneficial for IRB staff and members who are involved in reviewing research and trials involving suicidal and potentially suicidal individuals.
Webinar participants holding the Certified IRB Professional (CIP®) credential may apply 1.5 continuing education credits towards CIP recertification. Learn More »
*No endorsement of PRIM&R, its programs, or services, by NIH is intended.
Access to purchased content will be available for 30 days after the date of purchase. After 30 days, access to the content will be removed, but users will retain access to any certificates of attendance earned. Content purchased prior to January 1, 2021 will remain available indefinitely. After access has expired, users can purchase an additional 30 days of access.
If you'd prefer a paper form, please click here. Please send the completed form to firstname.lastname@example.org.
Please note that this content is also part of a bundle. Click here to see the full bundle array.